A physiological delay in human fetal hemoglobin switching is associated with specific globin DNA hypomethylation.
The human fetal-to-adult globin switch normally occurs on a fixed schedule, beginning at 32-34 weeks gestation, and recent studies have suggested an association between this developmental inactivation of the fetal (gamma) globin genes and the appearance of methylation within and around these genes. We have studied a population of infants in whom this switch does not occur before birth (infants of diabetic mothers, IDM) and examined the patterns of methylation surrounding their active gamma-globin genes, in comparison to the gamma-globin genes of age-matched controls who have switched their pattern of globin gene expression on schedule. All genomic DNA samples from infants with delays in the globin switch demonstrated extensive hypomethylation in the region of the gamma-globin genes, comparable to that found in the genomes of fetuses of less than 21 weeks gestation. DNA from the erythroid cells of infants of 32-40 weeks gestation had no detectable hypomethylation in the gamma-globin region. These findings support the concept that hypomethylation is an accurate developmental marker of globin gene switching, and suggest that globin gene expression in IDM may be arrested at an early preswitch stage.
D000328:Adult; D004247:DNA / Q000378:metabolism*; D003920:Diabetes Mellitus / Q000235:genetics; D005260:Female; D005319:Fetal Hemoglobin / Q000096:biosynthesis*; D005786:Gene Expression Regulation; D005819:Genetic Markers; D005865:Gestational Age; D005914:Globins / Q000235:genetics*; D006801:Humans; D007231:Infant, Newborn; D007328:Insulin / Q000235:genetics; D008297:Male; D008745:Methylation
D005819:Genetic Markers; D007328:Insulin; D005914:Globins; D004247:DNA; D005319:Fetal Hemoglobin